Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Repurchased
Growth Metrics
Income Statement
Others
Ratios

Pharma-Bio Serv (PBSV) Share-based Compensation (2016 - 2026)

Pharma-Bio Serv filings provide 17 years of Share-based Compensation readings, the most recent being $8619.0 for Q1 2026.

  • On a quarterly basis, Share-based Compensation fell 19.31% to $8619.0 in Q1 2026 year-over-year; TTM through Jan 2026 was $33017.0, a 23.97% decrease, with the full-year FY2025 number at $35079.0, down 26.22% from a year prior.
  • Share-based Compensation hit $8619.0 in Q1 2026 for Pharma-Bio Serv, up from $4399.0 in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $28445.0 in Q4 2022 to a low of $684.0 in Q4 2023.
  • Median Share-based Compensation over the past 5 years was $14400.0 (2022), compared with a mean of $12233.7.
  • Biggest five-year swings in Share-based Compensation: crashed 97.6% in 2023 and later surged 359.94% in 2024.
  • Pharma-Bio Serv's Share-based Compensation stood at $28445.0 in 2022, then crashed by 97.6% to $684.0 in 2023, then surged by 359.94% to $3146.0 in 2024, then skyrocketed by 39.83% to $4399.0 in 2025, then skyrocketed by 95.93% to $8619.0 in 2026.
  • The last three reported values for Share-based Compensation were $8619.0 (Q1 2026), $4399.0 (Q4 2025), and $9999.0 (Q3 2025) per Business Quant data.